Ensuring Compliance Against Drug Diversion Act of 2020

USA116^th CongressHR-4812| House

| Updated: 11/18/2020

Ensuring Compliance Against Drug Diversion Act of 2020 This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances. It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.

Bill Text Versions

View Text

4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Oct 23, 2019

Introduced in House

Oct 23, 2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Oct 26, 2019

Referred to the Subcommittee on Health.

Nov 15, 2019

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Sep 9, 2020

Committee Consideration and Mark-up Session Held.

Sep 9, 2020

Ordered to be Reported by Voice Vote.

Nov 16, 2020

Placed on the Union Calendar, Calendar No. 482.

Nov 16, 2020

Committee on the Judiciary discharged.

Nov 16, 2020

Reported by the Committee on Energy and Commerce. H. Rept. 116-584, Part I.

Nov 17, 2020

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

Nov 17, 2020

Considered under suspension of the rules. (consideration: CR H5819-5820)

Nov 17, 2020

DEBATE - The House proceeded with forty minutes of debate on H.R. 4812.

Nov 17, 2020

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5819)

Nov 17, 2020

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5819)

Nov 17, 2020

Motion to reconsider laid on the table Agreed to without objection.

Nov 18, 2020

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

October 23, 2019
Introduced in House
October 23, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
October 26, 2019
Referred to the Subcommittee on Health.
November 15, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
September 9, 2020
Committee Consideration and Mark-up Session Held.
September 9, 2020
Ordered to be Reported by Voice Vote.
November 16, 2020
Placed on the Union Calendar, Calendar No. 482.
November 16, 2020
Committee on the Judiciary discharged.
November 16, 2020
Reported by the Committee on Energy and Commerce. H. Rept. 116-584, Part I.
November 17, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
November 17, 2020
Considered under suspension of the rules. (consideration: CR H5819-5820)
November 17, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 4812.
November 17, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5819)
November 17, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5819)
November 17, 2020
Motion to reconsider laid on the table Agreed to without objection.
November 18, 2020
Received in the Senate and Read twice and referred to the Committee on the Judiciary.